Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Drug Delivery in Cancer' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Drug Delivery in Cancer Technologies, Markets and Companies |
March 2010 | £2310 | 100 % |
|
Intranasal Drug Delivery US Market Trends & Analysis |
November 2009 | £1980 | 38.5 % |
|
Drug Delivery Markets, Vol II Implantable Injectable |
February 2007 | £1650 | 35 % |
|
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems |
September 2009 | £1980 | 33.25 % |
|
Drug Delivery Markets Oral Delivery |
January 2007 | £1650 | 29.75 % |
|
Currently Druggable in Colorectal Cancer A Drug Target Competitive Analysis |
December 2008 | £1745 | 29.05 % |
|
Competitive Outlook on Non-Antibody Based Cancer Vaccines |
August 2006 | £1745 | 28.7 % |
|
Currently Druggable in Prostate Cancer A Drug Target Competitive Analysis |
September 2008 | £1745 | 28 % |
|
Currently Druggable in Breast Cancer A Drug Target Competitive Analysis |
August 2008 | £1745 | 27.65 % |
|
Innovations in Cancer Novel Therapeutics, New Diagnostics and Future R&D Strategies |
February 2007 | £1495 | 27.65 % |
|
Global Cancer Treatment Forecast to 2012 |
August 2008 | £1055 | 27.3 % |
|
Advanced Drug Formulation Design to Optimize Therapeutic Outcomes |
September 2007 | £115 | 27 % |
|
Chronotherapeutics |
September 2003 | £75 | 26.95 % |
|
Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
September 2006 | £1515 | 25.9 % |
|
Innovation in Drug Delivery The future of nanotechnology and non-invasive protein delivery |
November 2006 | £1495 | 25.55 % |
|
Guide to Valuation of Pharmaceutical Licensing Deals |
February 2009 | £1500 | 25.55 % |
|
Cell Therapy Technologies, Markets and Companies |
March 2010 | £3300 | 25 % |
|
Pipeline Insight: Insulin Antidiabetics Return to Injections Alternative Delivery Methods Fall by The Wayside |
July 2008 | £3965 | 25 % |
|
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology |
December 2006 | £3090 | 24.15 % |
|
Oncology Market Forecast to 2013 |
July 2008 | £10765 | 24.15 % |
|
Currently Druggable in Melanoma A Drug Target Competitive Analysis |
October 2008 | £1745 | 23.1 % |
|
Drug Delivery Series I-IV |
April 2007 | £4720 | 23.1 % |
|
The Bourne Report – Medical Device Quarterly |
March 2008 | £2575 | 23.1 % |
|
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics |
April 2008 | £2015 | 23.1 % |
|
Antibody-Drug Conjugates (ADC) Competitor Analysis |
June 2009 | £225 | 23 % |
|
Biotechnology and Biopharmaceuticals Transforming Proteins and Genes into Drugs |
July 2003 | £55.95 | 22.4 % |
|
Nanotechnology in Health Care to 2009 |
May 2005 | £2775 | 22.05 % |
|
Transdermal Drug Delivery Technologies, Markets and Companies |
March 2010 | £1850 | 22.05 % |
|
Immunocytokines Competitor Analysis |
June 2009 | £135 | 22 % |
|
Drug Delivery Technology: Revolutionizing CNS Therapies |
December 2007 | £945 | 21.7 % |
|
Outlook for RNAi, 2007 siRNA and miRNA in biology, diagnostics and therapeutics |
June 2007 | £1495 | 21.5 % |
|
Australia Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2015 |
March 2009 | £1650 | 20.65 % |
|
Delivering New Biopharmaceutical Therapies Challenges & Opportunities |
January 2009 | £945 | 19.25 % |
|
Decoding Big Pharma's R&D Strategy in Oncology |
September 2007 | £1755 | 19.25 % |
|
Celsion Corporation - Financial and Strategic Analysis Review |
June 2009 | £83 | 19 % |
|
Innovative Drug R&D in China |
October 2009 | £1910 | 18.9 % |
|
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology |
August 2006 | £3090 | 18.9 % |
|
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Vaccines in Oncology |
August 2006 | £3090 | 18.9 % |
|
RNAi Therapeutics 2008 |
November 2007 | £2350 | 18.9 % |
|
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies |
May 2006 | £3090 | 18.9 % |
|
Nanotechnology Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics |
January 2008 | £1995 | 18.55 % |
|
Scrip Yearbook 2007 23rd Edition (2 Volumes) |
January 2006 | £895 | 18.55 % |
|
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players |
March 2008 | £1995 | 18.55 % |
|
NeoPharm, Inc. - SWOT Analysis |
October 2008 | £44 | 18.5 % |
|
Cancer Therapeutics Market Insight and R&D Pipeline Analysis |
August 2008 | £2310 | 17.5 % |
|
Targeted Therapies in Oncology A World Review |
December 2006 | £4435 | 17.5 % |
|
RNA Interference for Drug R&D Applications, Alliances, Companies and WW Market to 2011 |
July 2007 | £1715 | 17.15 % |
|
Burger's Medicinal Chemistry and Drug Discovery 6 Volume Set |
March 2003 | £1730 | 17.15 % |
|
Stem Cell-Based Therapeutic Delivery Challenges & Opportunities |
December 2008 | £945 | 17.15 % |
|
Monoclonal Antibodies 2007 Competitive Landscape & Pipeline Insight |
January 2007 | £1485 | 16.8 % |
|
Drug Delivery Technology: Developing a New Generation of Vaccines |
November 2007 | £945 | 16.8 % |
|
Pancreatic Cancer: Industry Background Report List of Companies |
October 2005 | £235 | 16.5 % |
|
Liver Cancer: Industry Background Report List of Companies |
October 2005 | £235 | 16.5 % |
|
Prostate Cancer: Industry Background Report List of Companies |
October 2005 | £345 | 16.5 % |
|
CytoCore, Inc. - Financial and Strategic Analysis Review |
July 2009 | £83 | 16.5 % |
|
Breast Cancer: Industry Background Report List of Companies |
October 2005 | £345 | 16.5 % |
|
Lung cancer: Industry Background Report List of Companies |
October 2005 | £295 | 16.5 % |
|
Colorectal Cancer: Industry Background Report List of Companies |
October 2005 | £295 | 16.5 % |
|
Drug Targets for Breast Cancer |
January 2006 | £1095 | 16 % |
|
Emerging Opportunities in Cancer Nanomedicine |
August 2006 | £995 | 15.75 % |
|
Market for Bioengineered Protein Drugs; The |
January 2007 | £2885 | 15.75 % |
|
Drug Delivery Technologies: Players, products & prospects to 2015 |
November 2007 | £1795 | 15.75 % |
|
Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share |
November 2006 | £3965 | 15.75 % |
|
Commercial and Pipeline Insight: Opioids Short Acting and Anti-Abuse Technologies Set to Fragment and Grow The Market |
March 2008 | £5020 | 15.4 % |
|
Bulk Paclitaxel A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 15.4 % |
|
Prostate Cancer Therapeutics A Global Market Perspective |
November 2009 | £1980 | 14.7 % |
|
Molecular Diagnostics in Cancer Testing |
December 2009 | £2245 | 14.7 % |
|
Competitive Outlook of Cancer Drug Development The Missing Handbook to New Product Planning and Portfolio Planning |
August 2009 | £2195 | 14.7 % |
|
Nanotechnology in Health Care |
February 2007 | £2970 | 14.5 % |
|
Cancer Therapies Global Market Opportunities |
November 2009 | £1980 | 14.35 % |
|
Immunomodulators Therapeutic Needs, Pipelines & Prospects |
August 2007 | £1495 | 14.35 % |
|
RNAi Technologies, Markets and Companies |
March 2010 | £2310 | 14 % |
|
United Sates Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2015 |
March 2009 | £1650 | 14 % |
|
Renal Cell Carcimona Drug Discoveries - what the future holds |
February 2010 | £1295 | 14 % |
|
Stakeholder Opinions Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies |
July 2008 | £2510 | 14 % |
|
Medical Nanotechnology Markets |
September 2008 | £2245 | 13.65 % |
|
Drug Delivery in Central Nervous System Diseases Technologies,Markets and Companies |
October 2009 | £1650 | 13.65 % |
|
Drug Delivery to CNS |
March 2010 | £1850 | 13.65 % |
|
Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities |
April 2006 | £1900 | 13.65 % |
|
Drug Delivery to Central Nervous System Diseases Technologies, Markets and Companies |
February 2010 | £1850 | 13.65 % |
|
Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking |
April 2009 | £1745 | 13.65 % |
|
Next Generation Protein Engineering and Drug Design Strategies to boost efficacy and improve drug delivery |
February 2007 | £1495 | 13.65 % |
|
Personalized Medicine: Technologies and the Global Market |
July 2009 | £3205 | 13.3 % |
|
Disposable Medical Supplies Markets |
August 2009 | £2245 | 13.3 % |
|
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
July 2007 | £1999 | 13.3 % |
|
Future of RNAi Therapeutics, The Drug Pipelines and Prospects |
September 2008 | £1995 | 13.3 % |
|
Stakeholder Opinions: Back Pain Gain competitive edge by targeting subpopulations |
March 2009 | £1320 | 12.95 % |
|
Cancer Cell Therapy Markets |
March 2008 | £2245 | 12.95 % |
|
Medical Imaging Markets, Volume V Molecular Imaging |
May 2007 | £1980 | 12.95 % |
|
Modern Biopharmaceuticals Design, Development and Optimization, 4 Volumes |
September 2005 | £440 | 12.95 % |
|
EU Pharma IMPACTS |
August 2005 | £450 | 12.95 % |
|
Gene Therapy Worldwide Market Challenges & Opportunities |
November 2009 | £1980 | 12.95 % |
|
Stakeholder Opinions: Primary Brain Cancer Temozolomide Turns Heads |
July 2007 | £1320 | 12.6 % |
|
Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 |
May 2008 | £1980 | 12.6 % |
|
Drug-Device Combinations The Global Market |
January 2010 | £3205 | 12.6 % |
|
Preclinical Cancer Therapeutics 2007 Decoding Next Generation Drug Targets for Market Success |
December 2006 | £1600 | 12.6 % |
|
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012 |
December 2008 | £2310 | 12.25 % |
|
Nanomedicine |
July 2009 | £2610 | 12.25 % |
|
Pipeline Insight: Cancer Overview Increasing Diversity Offers Both High Risk And Reward |
September 2007 | £5020 | 11.9 % |
|
Stakeholder Insight: Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer good value? |
December 2006 | £3965 | 11.9 % |
|
RNA Interference Markets |
December 2008 | £2245 | 11.55 % |
|
Infusion Devices: Technologies and Global Markets |
February 2010 | £3205 | 11.55 % |
|
China Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 |
May 2008 | £1980 | 11.55 % |
|
Global Protein Therapeutics Market Analysis |
August 2009 | £1190 | 11.55 % |
|
The Global Market for Pain Management Drugs and Devices |
August 2009 | £3205 | 10.85 % |
|
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape |
October 2007 | £1980 | 10.85 % |
|
Bladder Cancer Therapeutics |
February 2010 | £2610 | 10.5 % |
|
Pain Therapeutics Drugs, Markets and Companies |
March 2010 | £2310 | 10.5 % |
|
Commercial Insight: Pain Market Overview Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth |
October 2008 | £5285 | 10.5 % |
|
Human Vaccines Global Market Opportunities |
November 2009 | £1980 | 10.15 % |
|
Nanobiotechnology Applications, Markets and Companies |
March 2010 | £2970 | 10.15 % |
|
Computed Tomography Systems Clinical Trial Analysis |
July 2009 | £660 | 10.15 % |
|
Nanobiotechnology |
February 2010 | £2940 | 10.15 % |
|
The US Pharmaceutical Market 2009-2024 |
November 2009 | £1499 | 10.15 % |
|
United States Drug Delivery Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies |
April 2008 | £1980 | 10.15 % |
|
Global Protein Therapeutics Market, The Market Dynamics and Pipeline Analysis |
December 2006 | £1980 | 10.15 % |
|
The Global Pain Market 2008-2023 |
November 2008 | £1499 | 10.15 % |
|
Disposable Medical Supplies US industry forecasts for 2013 & 2018 |
July 2009 | £3170 | 10.15 % |
|
Biomarkers The Expanding Global Market |
November 2007 | £3205 | 9.8 % |
|
Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth |
April 2009 | £3965 | 9.8 % |
|
The World Market for Gynaecology 2007-2017 |
September 2007 | £3200 | 9.8 % |
|
Antiviral Therapeutics Technologies, Markets and Companies |
March 2010 | £2115 | 9.8 % |
|
Cell Therapy Markets |
July 2007 | £2245 | 9.45 % |
|
Nitric Oxide Therapeutics, Markets and Companies |
March 2010 | £1850 | 9.1 % |
|
Global Vaccines Market 2008-2023, The |
August 2008 | £1499 | 9.1 % |
|
Gene Therapy Technologies, Markets and Companies |
March 2010 | £2970 | 9.1 % |
|
Rimonabant: The first of the Cannabinoid blockbusters |
June 2007 | £1499 | 8.75 % |
|
Monoclonal Antibody Therapeutics 2009-2024 |
August 2009 | £1499 | 8.75 % |
|
Medical Weekly Deals Summaries 18 May 2009 |
May 2009 | £83 | 8.75 % |
|
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market |
April 2008 | £5285 | 8.4 % |
|
Nanomedicine 2006-2011 |
June 2006 | £1499 | 8.4 % |
|
Personalized Medicine Scientific & Commercial Aspects |
March 2010 | £2640 | 7.7 % |
|
Global Biotech Market Analysis and Forecasts, 2008-2023 |
August 2008 | £1499 | 7.7 % |
|
Clinical Trials Business; The |
August 2006 | £2885 | 7.7 % |
|
Growth Factors (Blood and Tissue) A World Report |
November 2009 | £1980 | 6.65 % |
|
Animal Biotechnology Technologies, Markets and Companies |
March 2010 | £1650 | 6.65 % |
|
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007 |
June 2007 | £1999 | 6.3 % |
|
The Executive Guide to Molecular Imaging |
July 2007 | £595 | 5.95 % |
|
Imaging Agents A Worldwide Market Review |
November 2009 | £1980 | 5.95 % |
|
Women's Reproductive Disorders Therapeutics 2008-2018 |
September 2008 | £1499 | 5.25 % |
|
Antiageing and Life Enhancement Pharmacotherapeutics |
January 2006 | £795 | 5.25 % |
|
Partneringreview 2006 – Industry Sector Volume 6 |
February 2006 | £1395 | 4.5 % |
|
Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands Healthcare |
March 2009 | £5285 | 4.2 % |
|
Protein Therapeutics Market; The The Science and Business of a Growing Sector |
June 2006 | £2575 | 4.2 % |
|
Point of Care Diagnostics: Players, Products & Future Market Prospects |
November 2009 | £995 | 3.85 % |
